UKMC MS313, Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.
5037 BSRB, Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
J Alzheimers Dis. 2020;78(4):1419-1438. doi: 10.3233/JAD-200109.
In animal models and tissue preparations, calcium dyshomeostasis is a biomarker of aging and Alzheimer's disease that is associated with synaptic dysfunction, neuritic pruning, and dysregulated cellular processes. It is unclear, however, whether the onset of calcium dysregulation precedes, is concurrent with, or is the product of pathological cellular events (e.g., oxidation, amyloid-β production, and neuroinflammation). Further, neuronal calcium dysregulation is not always present in animal models of amyloidogenesis, questioning its reliability as a disease biomarker.
Here, we directly tested for the presence of calcium dysregulation in dorsal hippocampal neurons in male and female 5×FAD mice on a C57BL/6 genetic background using sharp electrodes coupled with Oregon-green Bapta-1 imaging. We focused on three ages that coincide with the course of amyloid deposition: 1.5, 4, and 10 months old.
Outcome variables included measures of the afterhyperpolarization, short-term synaptic plasticity, and calcium kinetics during synaptic activation. Quantitative analyses of spatial learning and memory were also conducted using the Morris water maze. Main effects of sex, age, and genotype were identified on measures of electrophysiology and calcium imaging.
Measures of resting Oregon-green Bapta-1 fluorescence showed significant reductions in the 5×FAD group compared to controls. Deficits in spatial memory, along with increases in Aβ load, were detectable at older ages, allowing us to test for temporal associations with the onset of calcium dysregulation.
Our results provide evidence that reduced, rather than elevated, neuronal calcium is identified in this 5×FAD model and suggests that this surprising result may be a novel biomarker of AD.
在动物模型和组织准备中,钙稳态失调是衰老和阿尔茨海默病的生物标志物,与突触功能障碍、神经突修剪和细胞过程失调有关。然而,钙稳态失调的发生是早于、同时还是晚于病理细胞事件(如氧化、淀粉样蛋白-β产生和神经炎症)尚不清楚。此外,在淀粉样蛋白形成的动物模型中并非总是存在神经元钙稳态失调,这使其作为疾病生物标志物的可靠性受到质疑。
本研究使用带有 Oregon-green Bapta-1 成像的尖锐电极,直接在 5×FAD 雄性和雌性小鼠的背海马神经元上检测钙稳态失调的存在情况,这些小鼠具有 C57BL/6 遗传背景。我们重点研究了三个与淀粉样蛋白沉积过程一致的年龄:1.5、4 和 10 个月大。
研究结果变量包括突触激活后超极化、短期突触可塑性和钙动力学的测量。还使用 Morris 水迷宫对空间学习和记忆进行了定量分析。性别、年龄和基因型的主要影响因素可通过电生理学和钙成像来进行测量。
Oregon-green Bapta-1 荧光的静息测量值显示,5×FAD 组与对照组相比明显降低。在年龄较大时,空间记忆缺陷以及 Aβ负荷增加,这使我们能够测试钙稳态失调发生的时间关联。
我们的研究结果提供了证据,表明在该 5×FAD 模型中,神经元钙减少而不是增加,这表明这一令人惊讶的结果可能是 AD 的一个新的生物标志物。